Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 300 of 672 entries
View as:

An Open-label, Multi-center Study Evaluating the Validity, Reliability, and Responsiveness of a New Female-specific Angina Questionnaire in Women With Chronic Angina Treated With Ranolazine Extended-release Tablets (CVT 3041)

Phase: N/A Priority: Normal
NCT ID: NCT00644332 Org: User:
Start: 11/30/07 End: 01/31/11 Due: 01/31/12

Observational Study on Prevalence of Host and Viral Genotypes in Chronic Hepatitis B and Hepatitis C Patients in India

Phase: N/A Priority: Normal
NCT ID: NCT01772121 Org: User:
Start: 05/31/12 End: 10/31/12 Due: 10/31/13

Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection and Child-Pugh Class B Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT02201901 Org: User:
Start: 07/31/14 End: 11/30/15 Due: 11/30/16

Study Evaluating Fosfomycin/Tobramycin for Inhalation in Cystic Fibrosis Patients With Pseudomonas Aeruginosa Lung Infection

Phase: N/A Priority: Normal
NCT ID: NCT00794586 Org: User:
Start: 11/30/08 End: 03/31/10 Due: 03/31/11

Study of Magrolimab Combination Therapy in Patients With Non-Surgically Removable Locally Advanced or Metastatic Triple-Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04958785 Org: User:
Start: 12/14/21 End: 10/08/24 Due: 10/08/25

Study of Aztreonam for Inhalation in Children With Cystic Fibrosis and New Infection of the Airways by Pseudomonas Aeruginosa Bacteria

Phase: N/A Priority: Normal
NCT ID: NCT03219164 Org: User:
Start: 11/28/17 End: 09/23/21 Due: 09/23/22

Study to Evaluate the Effect of Eleclazine on QT, Safety, and Tolerability in Participants With Long QT2 Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02365506 Org: User:
Start: 07/20/15 End: 06/13/16 Due: 06/13/17

Evaluating Ventricular Arrhythmia in Subjects With Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy-Defibrillator

Phase: N/A Priority: Normal
NCT ID: NCT02104583 Org: User:
Start: 09/30/14 End: 10/31/16 Due: 10/31/17

Safety and Efficacy of Tenofovir DF in HIV-1 Infected Adolescents Failing Their Current Antiretroviral Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00352053 Org: User:
Start: 06/30/06 End: 12/31/13 Due: 12/31/14

Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of MBX-2982 Administered Daily for 4 Weeks as Monotherapy in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01035879 Org: User:
Start: 12/31/09 End: 08/31/10 Due: 08/31/11

Cidofovir as a Treatment for Herpes Simplex in Patients With AIDS

Phase: N/A Priority: Normal
NCT ID: NCT00002181 Org: User:
Start: - End: - Due: -

Aztreonam Lysine for Pseudomonas Infection Eradication Study

Phase: N/A Priority: Normal
NCT ID: NCT01375049 Org: User:
Start: 08/31/11 End: 05/31/13 Due: 05/31/14

Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC

Phase: N/A Priority: Normal
NCT ID: NCT02469246 Org: User:
Start: 06/29/15 End: 03/13/19 Due: 03/13/20

Study of Lenacapavir Taken Twice a Year for HIV Pre-Exposure Prophylaxis (PrEP)

Phase: N/A Priority: Normal
NCT ID: NCT06513312 Org: User:
Start: 10/07/24 End: 12/31/28 Due: 12/31/29

Study of Dalutrafusp Alfa (Formerly GS-1423) in Participants With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03954704 Org: User:
Start: 06/03/19 End: 04/15/21 Due: 04/15/22

CHARM: Chronic Hepatitis B Antihepadnaviral Resistance Mutation Study

Phase: N/A Priority: Normal
NCT ID: NCT00645736 Org: User:
Start: 02/29/08 End: 11/30/08 Due: 11/30/09

A Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Therapies.

Phase: N/A Priority: Normal
NCT ID: NCT01510561 Org: User:
Start: 03/31/12 End: 09/30/15 Due: 09/30/16

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Are Naive to Biologic Disease-Modifying Antirheumatic Drug Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04483700 Org: User:
Start: 12/31/20 End: 06/30/24 Due: 06/30/25

Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Cholangitis (PSC)

Phase: N/A Priority: Normal
NCT ID: NCT02247934 Org: User:
Start: 10/31/14 End: 10/31/15 Due: 10/31/16

Evaluation of Long-Acting Lenacapavir for the Treatment of HIV-1 in Treatment-experienced Adolescents and Children

Phase: N/A Priority: Normal
NCT ID: NCT06749054 Org: User:
Start: 03/26/25 End: 12/31/26 Due: 12/31/27

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as Monotherapy and in Combination With Anticancer Therapies in Adults With Solid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT05006794 Org: User:
Start: 09/15/21 End: 03/31/29 Due: 03/31/30

The Safety and Effectiveness of PMPA Prodrug in HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00002396 Org: User:
Start: - End: - Due: -

Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic HCV Infection

Phase: N/A Priority: Normal
NCT ID: NCT02201940 Org: User:
Start: 07/31/14 End: 09/30/15 Due: 09/30/16

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Phase: N/A Priority: Normal
NCT ID: NCT01320943 Org: User:
Start: 04/26/11 End: 08/23/16 Due: 08/23/17

Study to Investigate Effects of CAL-263 in Subjects With Allergic Rhinitis Exposed to Allergen in an Environmental Chamber

Phase: N/A Priority: Normal
NCT ID: NCT01066611 Org: User:
Start: 01/31/10 End: 04/30/10 Due: 04/30/11